News

Norsk Hydro Board Proposes NOK 2.25 Dividend for Shareholders

Norsk Hydro Board Proposes NOK 2.25 Dividend for Shareholders

Norsk Hydro's Proposal for a Cash Dividend

Norsk Hydro ASA is making an exciting move for its shareholders by proposing a dividend of NOK 2.25 per share. This decision comes as a result of the company's financial outcomes for the year 2024, signaling its commitment to rewarding investors.

Details of the Proposed Dividend

The proposed dividend is structured as follows:

• Dividend Amount: NOK 2.25 per share

• Declared Currency: NOK

• Last Day to Include Right: May 9, 2025

• Ex-Date: May 12, 2025

• Record Date: May 13, 2025

• Payment Date: May 20, 2025

• Date of Approval: May 9, 2025

Communication with Investors

Norsk Hydro places a strong emphasis on transparency and open communication with its investors. For any inquiries regarding the dividend or related matters, shareholders can reach out to the investor relations contact:

Martine Rambøl Hagen
Tel: +47 91708918
Email: martine.rambol.hagen@hydro.com

Regulatory Compliance

This information adheres to the disclosure requirements under Section 5-12 of the Norwegian Securities Trading Act. Norsk Hydro is committed to maintaining ethical standards and ensuring proper communication with its stakeholders.

Understanding Norsk Hydro's Financial Landscape

As a prominent player in the global aluminum industry, Norsk Hydro's decisions regarding dividends reflect its robust financial health and profitability. The proposed dividend is not just a token of appreciation for shareholders; it's also a testament to the company's ongoing initiatives aimed at sustainable growth.

With its operations expanding across various regions, Norsk Hydro continually adapts to market dynamics, thus enhancing shareholder value. Notably, the company engages in innovative practices and explores new opportunities, ensuring its market position remains competitive.

Frequently Asked Questions

What is the proposed dividend amount by Norsk Hydro?

The board has proposed a dividend of NOK 2.25 per share.

When will the dividend be paid out?

The payment date for the proposed dividend is May 20, 2025.

Who can be contacted for investor inquiries?

Investors can contact Martine Rambøl Hagen at +47 91708918 or via email at martine.rambol.hagen@hydro.com.

What are the key dates related to the proposed dividend?

The key dates include the last day including the right (May 9, 2025), ex-date (May 12, 2025), record date (May 13, 2025), and payment date (May 20, 2025).

How does the dividend proposal reflect on Norsk Hydro's performance?

The proposed dividend indicates Norsk Hydro's strong financial performance for the year 2024 and its commitment to shareholder value.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 1

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Softcare Facilitates Standards Delegation Visit to Senegal

Updated Category News Views 3

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Continue Reading

Top 5 Most Recently Viewed Articles

Prinses Máxima Center Enhances Genomics with Callisto™ Innovation

Updated Category News Views 194

Prinses Máxima Center's Partnership with Volta Labs The Prinses Máxima Center for Pediatric Oncology is making headlines with its recent acquisition of the Callisto™ platform from Volta Labs. This major step forward aims to enhance efficiency in sample preparation across a variety of genomics workflows, specifically designed for both Illumina and Oxford Nanopore...

Continue Reading
Boise Hunter Homes Appoints Industry Veteran Julie DeLorenzo

Updated Category News Views 474

Julie DeLorenzo Joins Boise Hunter Homes Boise Hunter Homes welcomes Julie DeLorenzo to its team as the new Director of Community Relations. This strategic move emphasizes the company’s commitment to community building and corporate stewardship. Experience and Community Commitment DeLorenzo comes with extensive experience as an Idaho Realtor, and her dedication to...

Continue Reading
Growth Prospects for Glass Prefilled Syringes in Europe

Updated Category News Views 151

Emerging Trends in the European Market for Glass Prefilled Syringes The market for glass prefilled syringes and vials in Europe is undergoing significant transformations as we witness a rapid development in healthcare and biotechnology sectors. The competitive landscape is shifting, with the adoption of innovative packaging techniques, the rise of biologics as a treatment...

Continue Reading
Man Group PLC Announces Significant Shareholdings Update

Updated Category News Views 112

Clarifying Share Interests of Man Group PLC Understanding the ownership structure in the financial world is crucial for investors. In compliance with the rules set out by the Takeover Code, disclosures regarding significant shareholdings need to be clear and transparent. Recently, Man Group PLC has taken steps to outline its relevant investments, specifically in relation...

Continue Reading
Nutrien Faces Downgrade as UBS Revises Outlook and Price Target

Updated Category News Views 87

UBS Downgrades Nutrien's Rating Amid Agricultural Concerns UBS has recently made headlines by downgrading Nutrien (NYSE: NTR) from a "buy" to a "neutral" rating. This adjustment reflects growing concerns about the agricultural market's performance and the potential impact on the company’s financial health. Weaker Agricultural Market Outlook Analysts at UBS have...

Continue Reading